These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 38762358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    Wolff E, Widgren K, Scalia Tomba G, Roth A, Lep T, Andersson S.
    PLoS One; 2021; 16(5):e0251644. PubMed ID: 33984060
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan.
    Hoshi SL, Seposo X, Shono A, Okubo I, Kondo M.
    Vaccine; 2019 Jun 12; 37(27):3588-3597. PubMed ID: 31153691
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.
    Prosser LA, Harpaz R, Rose AM, Gebremariam A, Guo A, Ortega-Sanchez IR, Zhou F, Dooling K.
    Ann Intern Med; 2019 Mar 19; 170(6):380-388. PubMed ID: 30776797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
    Hoshi SL, Kondo M, Okubo I.
    Vaccine; 2017 May 31; 35(24):3264-3271. PubMed ID: 28479176
    [Abstract] [Full Text] [Related]

  • 10. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS, King PG.
    Hum Exp Toxicol; 2014 Aug 31; 33(8):886-93. PubMed ID: 24275643
    [Abstract] [Full Text] [Related]

  • 11. The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
    Suh J, Lee T, Choi JK, Lee J, Park SH.
    Vaccine; 2021 Apr 28; 39(18):2575-2583. PubMed ID: 33814230
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
    Ahern S, Browne J, Murphy A, Teljeur C, Ryan M.
    Vaccine; 2024 May 22; 42(14):3321-3332. PubMed ID: 38609807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT.
    Hum Vaccin Immunother; 2016 Jul 02; 12(7):1766-76. PubMed ID: 26835890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.